9 Giugno 2025: International Congress in Neuro-Oncology in Padova with important experts and opinion leaders in the field of neuro-oncology! Free registration: events-communication.com/event/mastercl… #glioblastoma #meningioma #lowgradegliomas EORTC SNO AIOM IOV - Istituto Oncologico Veneto

We are proud to have a #CiteScore of 6.2 (2023) and an #ImpactFactor of 3.7 at #NeuroOncology Advances. Find out more reasons to #publish your #research with us here: bit.ly/4iKQHjS

Great talk yesterday with over 350 attendees! Thanks to all the moderators and speakers for the brilliant success!

In the Journal of Neuro-Oncology, the Stanford neurosurgery team studied PIK3CA-mutated meningiomas looking at targeted therapy approaches.

🎉 Congratulations Dr. Bennett, Dr. Levine, Dr. Nobre and the contributing authors on our Nature Cancer publication “A population-based analysis of the molecular landscape of glioma in adolescents and young adults reveals insights into gliomagenesis” rdcu.be/em0BS

Nuovo trial clinico multicentrico italiano per pazienti affetti da #meningioma SNO EANO AIOM International Consortium on Meningiomas (ICOM) Meningioma UK Meningioma

Special Issue on primary brain tumors!! Unraveling the Molecular Landscape of Primary Brain Tumors mdpi.com/si/241381 #mdpiijms via IJMS MDPI

Final Update CATNON ASCO 2025 · Median F/U 11 yrs · NO sig benefit concurrent TMZ · Sig benefit (HR 0.54) Adjuvant TMZ in IDHm (median OS 12.5 years) · NO benefit w/TMZ for IDHwt

Congrats for this important study in neuro-oncology at ASCO25! EANO AIOM

È tra i 16 giovani oncologi premiati al congresso internazionale di oncologia ASCO25. Congratulazioni alla nostra Dr. ssa Marta Padovan del team neuroncologico dello IOV - Istituto Oncologico Veneto per il meritato premio! Conquer Cancer, the ASCO Foundation Marta Padovan EANO IOV - Istituto Oncologico Veneto

Such Amazing tour in Padua in Palazzo del Bo , site of the Aula Magna of the University of Padua, One of the ancient University of the world. Galileo Galilei and Petrarca were teachers here. Tomorrow the neurooncology masterclass organized by Lombardi Giuseppe

3 inspiring lectures at the Masterclass in #Neuroncology @ Padova 📍 Longitudinal sampling: a new frontier in GBM treatment – E. Antonio Chiocca, MD, PhD, FAANS 📍 Overcoming, bypassing & disrupting the BBB – Ahmed Idbahi 📍 A bridge over troubled waters: making vaccines work in GBM – David Reardon

Day on Brain Tumors with National and International Specialists - Lombardi Giuseppe oncodaily.com/url/310516 #Cancer #OncoDaily #Oncology #GlobalAwareness #FightAgainstCancer #CancerWorld

We are proud to have a very easy and straightforward article submission process, with ease of use and quick submission to decision. Learn more here: bit.ly/3UvsGUl #NeuroOncologyAdvances #NeuroOncology #oncology #CancerResearch

As a top enroller PI in the EORTC LEGATO trial, I believe re-irradiation plus lomustine could offer an effective approach for recurrent glioblastoma. I encourage all sites to support enrollment and help generate practice-changing evidence.”

This cohort study suggests that chromosomal alterations should be included in the WHO grading criteria for meningiomas, as they are associated with worse outcomes and can refine the current classification system. ja.ma/44mXMC4 Alireza Mansouri Andrew Gao

Here new recommendations for the use of PET imaging in patients with gliomas from RANO working group and the EANO Update to the RANO working group and EANO recommendations for the clin... sciencedirect.com/science/articl… Sapienza Università di Roma Norbert Galldiks

Prognostic value of 1D, 2D, and volumetric tumor size increases in recurrent WHO grade 2 and 3 meningiomas: Radiological post-hoc analysis of the EORTC-BTG-1320 trial - PubMed pubmed.ncbi.nlm.nih.gov/40735273/

Congrats for this brilliant work and thanks for involving me !!

I am honoured to be leading this Italian, academic trial for patients with meningioma! Thanks to all the Centers involved in this study and neuro-oncology team at Istituto Oncologico Veneto IOV - IRCCS #meningioma #regorafenib Marta Padovan AIOM trialsjournal.biomedcentral.com/articles/10.11…